The Valley Desk

NCT04013854 · Interventional trial

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Overall registry status Active not recruiting

Phase 2

Conditions Melanoma, Melanoma Stage III

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov